Iran able to produce 600m doses of COVID vaccines annually

March 9, 2022 - 17:27

TEHRAN – Thanks to the capacity of knowledge-based companies, Iran is able to produce 600 million doses of vaccine against coronavirus annually, the head of the Food and Drug Administration, has said.

A total of 21 knowledge-based companies are operating to produce 50 million doses of vaccine monthly and 600 million doses annually, IRNA quoted Bahram Daraei as saying on Wednesday.

Iran is the sixth country in the world and the first country in West Asia to gain the ability to produce the Coronavirus vaccine.

Considering that five coronavirus vaccines have so far been produced domestically, Mohammad Reza Shanehsaz, the former head of the Food and Drug Administration, said in June 2021 that Iran is one of the few countries that has all vaccine production platforms.

COVIRAN is the first vaccine in West Asia that is in the process of global registration.

On February 7, ISNA reported that two domestic companies have completed the animal phase of a clinical study to develop vaccines against the Omicron strain.

Domestically-made vaccines

Made by researchers at the Headquarters for Executing the Order of the Imam, COVIRAN BARKAT was unveiled on December 29, 2020, and received the license for public use on June 14.

Developed by the Razi Vaccine and Serum Research Institute, Razi Cov Pars is the second Iranian-made vaccine that started the clinical trial on February 27.

Moreover, the Iranian-Australian Spikogen vaccine and Pastu Covac, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, are other vaccines, which have received the emergency use license.


Leave a Comment

6 + 11 =